Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases. | ||||||
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases. | ||||||
Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens. | ||||||
Akouos is a Brookline, Massachusetts-based biotechnology company developing precision genetics-based medicines founded in 2016 by Emmanuel Simons. | ||||||
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias | ||||||
Affinia Therapeutics is a biotechnology company based in Waltham, Massachusetts that specializes in the development of gene therapies. | ||||||
Keros Therapeutics is a rare Muscle Disorders founded in 2016 by Paul Yu, Greg Cuny and Randall Peterson. | ||||||
Nocion Therapeutics is developing positively charged versions of "caines" -- broadly acting intracellular sodium channel blockers | ||||||
Sebacia is a Duluth, Georgia-based company founded in 2010. | ||||||
A group of company developing biopharmaceutical drugs, proteins and peptides to treat metabolic and rare diseases | ||||||
Swanbio Therapeutics Limited is a London-based company founded in 2017 by Florian Eichler, Karen Kozarsky and Rachel Salzman. | ||||||
Syntimmune is a Boston-based company. | ||||||
Alizé Pharma is a company founded in 2015. | ||||||
Company | ||||||
Campus Shift is a company founded in 2011. |